Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00537303 · ClinicalTrials.gov registry record · Phase 4
Comparison of the Blood Sugar Lowering Effect and Safety of Two Insulin Treatments in Type 2 Diabetes
A Phase 4 study, sponsored by Novo Nordisk A/S.
- Completed
- Registry status
- Phase 4
- Development phase
- 296
- Enrollment target
NCT00537303 is a Phase 4 study that has completed, run by Novo Nordisk A/S. The registered enrollment target is 296 participants.
The verdict
NCT00537303, a Phase 4 study, has completed, sponsored by Novo Nordisk A/S.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 296 participants
- Enrollment target
Study Summary
This trial is conducted in Europe, Africa and the United States of America (USA). The aim of this trial is to compare the safety and efficacy of two different insulin treatments, the "basic" and the "advanced" treatment in type 2 diabetes.
Interventions
- DRUG insulin aspart
- DRUG insulin detemir
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 296 participants |
| Start Date | 2007-10 |
| Est. Completion | 2009-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00537303
The ClinicalTrials.gov registry entry for NCT00537303 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 296 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novo Nordisk A/S, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which insulin aspart is the first listed.
NCT00537303 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00537303 about?
NCT00537303 is a clinical study titled "Comparison of the Blood Sugar Lowering Effect and Safety of Two Insulin Treatments in Type 2 Diabetes". This trial is conducted in Europe, Africa and the United States of America (USA). The aim of this trial is to compare the safety and efficacy of two different insulin treatments, the "basic" and the "advanced" treatment in type 2 diabetes.
What is the current status of trial NCT00537303?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 296 participants. The study started on 2007-10. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00537303?
The interventions under investigation include: insulin aspart (DRUG), insulin detemir (DRUG).
Who is sponsoring clinical trial NCT00537303?
This trial is sponsored by Novo Nordisk A/S, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.